Tempus Small Cell Lung Cancer Observational Study (Sculptor)
Recruiting now
Conditions studied: Small Cell Lung Cancer
In brief
The study is a non-interventional evaluation of participants with extensive stage (ES) SCLC who will receive diagnostic and (where possible) post-progression tumor tissue profiling, alongside plasma ctDNA and CTC biomarker profiling during standard of care therapy in both first and second line treatment.
Key facts
- Study ID
- NCT05257551
- Run by
- Tempus AI
- People needed
- 200
- Starts
- 2022-07-13
- Expected to finish
- 2029-03-01
- Last updated by the study team
- 2026-06-15
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Cancer Care Association of York — York, Pennsylvania, United States (enrolling)
- University of Colorado — Aurora, Colorado, United States (enrolling)
- Illinois Cancer Care — Peoria, Illinois, United States (enrolling)
- Johns Hopkins University — Baltimore, Maryland, United States (enrolling)
- University of North Carolina — Chapel Hill, North Carolina, United States (enrolling)
- TriHealth Cancer Institute — Cincinnati, Ohio, United States (enrolling)
- Ohio State University — Columbus, Ohio, United States (enrolling)
- Cancer and Blood Specialty Clinic — Los Alamitos, California, United States
- Englewood Health Medical Center — Englewood, New Jersey, United States
- OhioHealth Research Institute — Columbus, Ohio, United States
- Oklahoma Cancer Specialists and Research Institutes — Tulsa, Oklahoma, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.